Inventor
NGUYEN PHONG
AU82 patents
⚠️ This page may combine multiple inventors who share the name “NGUYEN PHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEC CORP
25 patentsUS10045191B2Aug 7, 2018
Method for use in device-to-device communication, wireless communication system, and architecture
NEC CORP22 citations93
US11284387B2Mar 22, 2022
Methods and system for device-to-device communication
NEC CORP9 citations86
US10735144B2Aug 4, 2020
Method and system for configuring device-to-device communication
NEC CORP4 citations83
US10405307B2Sep 3, 2019
Method for realizing eCA supporting up to 32 CCs and enhancing dynamic PUCCH resource allocation for associated use
NEC CORP7 citations83
US10200159B2Feb 5, 2019
Method and system for configuring device-to-device communication
NEC CORP5 citations83
US9532204B2Dec 27, 2016
Cellular network assisted device to device (D2D) discovery
NEC CORP9 citations83
US11689903B2Jun 27, 2023
System and method for vehicular data communication
NEC CORP4 citations75
US7362741B2Apr 22, 2008
Method and apparatus for wireless communication network operating in compressed mode
NEC CORP8 citations74
US11363428B2Jun 14, 2022
System and method for providing vehicular communication in an advanced wireless network
NEC CORP3 citations73
US10952043B2Mar 16, 2021
Vehicle to everything (V2X) communication method and system
NEC CORP5 citations73
US10314094B2Jun 4, 2019
System and method for data communication
NEC CORP1 citations73
US10314048B2Jun 4, 2019
Method for PHICH resource allocation
NEC CORP2 citations73
US10085171B2Sep 25, 2018
Method of controlling machine-type communications (MTC) in a wireless communications network
NEC CORP6 citations73
US9769591B2Sep 19, 2017
Method and system for machine type communication
NEC CORP6 citations73
US9717095B2Jul 25, 2017
Control signalling method
NEC CORP2 citations73
US9699781B2Jul 4, 2017
Communications node
NEC CORP4 citations73
US9615358B2Apr 4, 2017
Base station, method implemented thereby, and method implemented by user equipment
NEC CORP3 citations73
US9544102B2Jan 10, 2017
DL scheduling and HARQ-ACK feedback for DL transmissions in flexible-TDD systems without and with cross-subframe scheduling
NEC CORP5 citations73
US11770214B2Sep 26, 2023
Method and system for configuring device-to-device communication
NEC CORP1 citations72
US11398881B2Jul 26, 2022
Method and system for configuring device-to-device communication
NEC CORP3 citations72
US10375675B2Aug 6, 2019
Method and system for device-to-device communication
NEC CORP1 citations72
US12160803B2Dec 3, 2024
System and method for vehicular data communication
NEC CORP0 citations63
US11026280B2Jun 1, 2021
System and method for data communication
NEC CORP0 citations63
US10797919B2Oct 6, 2020
System and methods for realising adaptive radio access technology in 5G wireless communication system
NEC CORP1 citations63
US12368533B2Jul 22, 2025
Method and system for configuring device-to-device communication
NEC CORP0 citations62
EURO CELTIQUE SA
5 patentsUS7078426B2Jul 18, 2006
Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof
EURO CELTIQUE SA46 citations96
US6414011B1Jul 2, 2002
Aryl substituted pyrazoles, and pyrroles, and the use thereof
EURO CELTIQUE SA135 citations96
US6737418B2May 18, 2004
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
EURO CELTIQUE SA104 citations95
US6919363B2Jul 19, 2005
Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
EURO CELTIQUE SA45 citations92
US6867210B2Mar 15, 2005
Aryl substituted pyrimidines
EURO CELTIQUE SA49 citations92
VOLTERRA SEMICONDUCTOR CORP
2 patentsALLERGAN INC
2 patentsUS7276522B2Oct 2, 2007
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
ALLERGAN INC44 citations96
US7569584B2Aug 4, 2009
4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same
ALLERGAN INC4 citations63
RAPISCAN SYSTEMS INC
2 patentsNGUYEN PHONG
2 patentsMIRATI THERAPEUTICS INC
2 patentsGLOBALWAFERS CO LTD
2 patentsNOKIA CORP
1 patentRAPISCAN SECURITY PRODUCTS INC
1 patentTELCOM SEMICONDUCTOR INC
1 patentMODICA PETER
1 patentSIEW JIUN
1 patentSUNEDISON SEMICONDUCTOR LTD UEN201334164H
1 patentREDSIFT LTD
1 patentWAFERTECH INC
1 patentShowing the top 50 of 82 patents by PatentIndex Score.